BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

AVADEL PHARMACEUTICALS PLC — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Termination (No Activity)

AVADEL PHARMACEUTICALS PLC

via TREMONT STRATEGIES GROUP LLC (F/K/A ADS VENTURES)

1st Quarter (Jan 1 - Mar 31) · 2022Posted Mar 23, 2022Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: AVADEL PHARMACEUTICALS PLC
Description: pharmaceutical development
Location: Ireland

Registrant

Firm: TREMONT STRATEGIES GROUP LLC (F/K/A ADS VENTURES)
Description: government relations
Location: Boston, Massachusetts, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.